Nan Shan Life Insurance Co. Ltd. Sells 60,910 Shares of SPDR S&P Biotech ETF $XBI

Nan Shan Life Insurance Co. Ltd. trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 43.9% in the second quarter, Holdings Channel.com reports. The firm owned 77,701 shares of the exchange traded fund’s stock after selling 60,910 shares during the quarter. Nan Shan Life Insurance Co. Ltd.’s holdings in SPDR S&P Biotech ETF were worth $12,296,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Solstein Capital LLC grew its position in SPDR S&P Biotech ETF by 51.3% during the 2nd quarter. Solstein Capital LLC now owns 5,848 shares of the exchange traded fund’s stock worth $925,000 after acquiring an additional 1,983 shares during the last quarter. Rinkey Investments boosted its stake in shares of SPDR S&P Biotech ETF by 9.1% during the second quarter. Rinkey Investments now owns 1,828 shares of the exchange traded fund’s stock valued at $289,000 after purchasing an additional 153 shares in the last quarter. BTG Pactual Asset Management US LLC increased its stake in shares of SPDR S&P Biotech ETF by 15.1% in the second quarter. BTG Pactual Asset Management US LLC now owns 8,227 shares of the exchange traded fund’s stock valued at $1,302,000 after buying an additional 1,081 shares during the period. RPg Family Wealth Advisory LLC boosted its position in SPDR S&P Biotech ETF by 5.0% during the 2nd quarter. RPg Family Wealth Advisory LLC now owns 22,155 shares of the exchange traded fund’s stock worth $3,506,000 after buying an additional 1,046 shares during the period. Finally, Risk Paradigm Group LLC grew its holdings in SPDR S&P Biotech ETF by 6.1% during the 2nd quarter. Risk Paradigm Group LLC now owns 21,755 shares of the exchange traded fund’s stock worth $3,443,000 after acquiring an additional 1,246 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 0.6%

Shares of SPDR S&P Biotech ETF stock opened at $163.40 on Wednesday. The stock has a market cap of $10.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a twelve month low of $91.10 and a twelve month high of $169.89. The company’s fifty day moving average is $157.44 and its 200 day moving average is $139.75.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.